Clinic for Animal Reproduction, Faculty of Veterinary Medicine, Freie Universität Berlin, Koenigsweg 65, 14163 Berlin, Germany.
J Dairy Sci. 2013 May;96(5):2925-38. doi: 10.3168/jds.2012-6035. Epub 2013 Mar 15.
Subclinical ketosis (SCK) is defined as concentrations of β-hydroxybutyrate (BHBA) ≥ 1.2 to 1.4 mmol/L and it is considered a gateway condition for other metabolic and infectious disorders such as metritis, mastitis, clinical ketosis, and displaced abomasum. Reported prevalence rates range from 6.9 to 43% in the first 2 mo of lactation. However, there is a dearth of information on prevalence rates considering the diversity of European dairy farms. The objectives of this study were to (1) determine prevalence of SCK, (2) identify thresholds of BHBA, and (3) study their relationships with postpartum metritis, clinical ketosis, displaced abomasum, lameness, and mastitis in European dairy farms. From May to October 2011, a convenience sample of 528 dairy herds from Croatia, Germany, Hungary, Italy, Poland, Portugal, Serbia, Slovenia, Spain, and Turkey was studied. β-Hydroxybutyrate levels were measured in 5,884 cows with a handheld meter within 2 to 15 d in milk (DIM). On average, 11 cows were enrolled per farm and relevant information (e.g., DIM, postpartum diseases, herd size) was recorded. Using receiver operator characteristic curve analyses, blood BHBA thresholds were determined for the occurrence of metritis, mastitis, clinical ketosis, displaced abomasum, and lameness. Multivariate binary logistic regression models were built for each disease, considering cow as the experimental unit and herd as a random effect. Overall prevalence of SCK (i.e., blood BHBA ≥ 1.2 mmol/L) within 10 countries was 21.8%, ranging from 11.2 to 36.6%. Cows with SCK had 1.5, 9.5, and 5.0 times greater odds of developing metritis, clinical ketosis, and displaced abomasum, respectively. Multivariate binary logistic regression models demonstrated that cows with blood BHBA levels of ≥ 1.4, ≥ 1.1 and ≥ 1.7 mmol/L during 2 to 15 DIM had 1.7, 10.5, and 6.9 times greater odds of developing metritis, clinical ketosis, and displaced abomasum, respectively, compared with cows with lower BHBA blood levels. Interestingly, a postpartum blood BHBA threshold ≥ 1.1 mmol/L increased the odds for lameness in dairy cows 1.8 (95% confidence interval: 1.3 to 2.5) times. Overall, prevalence of SCK was high between 2 to 15 DIM and SCK increased the odds of metritis, clinical ketosis, lameness, and displaced abomasum in European dairy herds.
亚临床酮病 (SCK) 的定义为β-羟丁酸 (BHBA) 浓度≥1.2 至 1.4mmol/L,被认为是其他代谢和传染性疾病的门户条件,如子宫炎、乳腺炎、临床酮病和真胃移位。在泌乳的头 2 个月,报道的流行率范围为 6.9%至 43%。然而,考虑到欧洲奶牛场的多样性,关于流行率的信息却很少。本研究的目的是:(1)确定 SCK 的流行率,(2)确定 BHBA 的阈值,(3)研究其与产后子宫炎、临床酮病、真胃移位、跛行和乳腺炎的关系。2011 年 5 月至 10 月,对来自克罗地亚、德国、匈牙利、意大利、波兰、葡萄牙、塞尔维亚、斯洛文尼亚、西班牙和土耳其的 528 个奶牛场进行了便利抽样。在泌乳的 2 至 15 天内,使用手持计在 5884 头奶牛中测量了 BHBA 水平。平均每头农场有 11 头奶牛被纳入研究,记录了相关信息(例如,泌乳天数、产后疾病、牛群规模)。使用接收器操作特性曲线分析,确定了血液 BHBA 阈值,用于发生子宫炎、乳腺炎、临床酮病、真胃移位和跛行。对于每种疾病,都建立了多元二项逻辑回归模型,考虑奶牛为实验单位,牛群为随机效应。在 10 个国家中,SCK 的总流行率(即血液 BHBA≥1.2mmol/L)为 21.8%,范围为 11.2%至 36.6%。患有 SCK 的奶牛发生子宫炎、临床酮病和真胃移位的几率分别增加了 1.5、9.5 和 5.0 倍。多元二项逻辑回归模型表明,在泌乳的 2 至 15 天内,血液 BHBA 水平≥1.4、≥1.1 和≥1.7mmol/L 的奶牛发生子宫炎、临床酮病和真胃移位的几率分别增加了 1.7、10.5 和 6.9 倍,与血液 BHBA 水平较低的奶牛相比。有趣的是,产后血液 BHBA 阈值≥1.1mmol/L 会使奶牛跛行的几率增加 1.8 倍(95%置信区间:1.3 至 2.5)。总体而言,在泌乳的 2 至 15 天内,SCK 的流行率较高,SCK 增加了欧洲奶牛场子宫炎、临床酮病、跛行和真胃移位的几率。